As an addendum to the last post I am hoping that this management team will at least look for someone who has had experience in the upper reaches of management in biotech/pharmaceuticals, who has the contacts needed to start getting things going here. I would even welcome an addittion to the BOD in this regard.
Yes, I understand MS has contacts in acedemia and that is a good thing, but CYGX also needs contacts in the industry.
Apologize to hdhick and gdepc, I went a bit overboard with replacement thing, but just wanted to get my point across.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.